Springer Medicine (@Springer_Med) “What were the late breaking highlights from EAN 2026? In an exclusive interview,” — TopicDigg
Springer Medicine
@Springer_Med
加入 March 2023
0 正在关注 0 粉丝
What were the late breaking highlights from EAN 2026?
In an exclusive interview, Dr. Miguel Miranda discusses his takeaways on the ROSSINI trial findings, the latest results for anti-PACAP treatments for migraine, and the potential of GDF-15 for predicting cognitive decline.
显示更多
